A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities
Completed · Phase 2 · Has a placebo group
Conditions studied: Obesity, Overweight and Obesity
In brief
The main purpose of the study was to assess the effect of LY3502970 in participants who have obesity or are overweight.
Key facts
- Study ID
- NCT05051579
- Run by
- Eli Lilly and Company
- People needed
- 272
- Starts
- 2021-09-29
- Expected to finish
- 2022-11-22
- Last updated by the study team
- 2023-09-13
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Have a body mass index (BMI) of ≥30-kilogram square meter (kg/m²)
- Have a BMI ≥27 kg/m² and <30 kg/m² with at least 1 of the following weight-related comorbidities eg; [Have hypertension, or dyslipidemia, cardiovascular disease]
- Have had a stable body weight for the 3 months prior to randomization (not more than 5% body weight gain and/or loss)
You may not qualify if…
- Have any prior diagnosis of diabetes
- Have a prior or planned surgical treatment for obesity
- Have obesity induced by other endocrinological disorders or diagnosed monogenetic or syndromic forms of obesity
- Have renal impairment measured as estimated glomerular filtration rate (eGFR) <30 milliliter (mL)/minute (min)/1.73 m²
- Have a history of acute chronic pancreatitis
- Have a history of significant active or unstable Major Depressive Disorder (MDD) or other severe psychiatric disorder (for example, schizophrenia, bipolar disorder, or other serious mood or anxiety disorder) within the last 2 years Note: Participants with MDD or generalized anxiety disorder whose disease state is considered stable for the past 2 years and expected to remain stable throughout the course of the study, may be considered for inclusion if they are not on excluded medications.
- Within 3 months prior to screening:
- Have poorly controlled hypertension
- Have history of acute myocardial infarction
- Have history of cerebrovascular accident (stroke)
- Had hospitalization due to congestive heart failure (CHF)
- Have cancer
- Have human immunodeficiency virus (HIV) and/or positive HIV antibodies historically or at screening
- Have hepatitis B and/or positive hepatitis B surface antigen
Where it is running
- Anaheim Clinical Trials, LLC — Anaheim, California, United States
- John Muir Physician Network Research Center — Concord, California, United States
- NorCal Medical Research, Inc — Greenbrae, California, United States
- Valley Clinical Trials, Inc. — Northridge, California, United States
- Norcal Endocrinology & Internal Medicine — San Ramon, California, United States
- Elite Clinical Trials — Blackfoot, Idaho, United States
- Rocky Mountain Clinical Research — Idaho Falls, Idaho, United States
- StudyMetrix Research — City of Saint Peters, Missouri, United States
- Premier Research — Trenton, New Jersey, United States
- Lillestol Research — Fargo, North Dakota, United States
- Intend Research, LLC — Norman, Oklahoma, United States
- Capital Area Research, LLC — Camp Hill, Pennsylvania, United States
- Preferred Primary Care Physicians, Preferred Clinical Research-St. Clair — Pittsburgh, Pennsylvania, United States
- Dallas Diabetes Research Center — Dallas, Texas, United States
- Diabetes and Thyroid Center of Fort Worth — Fort Worth, Texas, United States
- Texas Diabetes & Endocrinology, P.A. — Round Rock, Texas, United States
- National Clinical Research, Inc — Richmond, Virginia, United States
- St. Vincent Hospital d/b/a Prevea Health — Green Bay, Wisconsin, United States
- C-health Research — Calgary, Alberta, Canada
- Wharton Medical Clinic — Hamilton, Ontario, Canada
- Bluewater Clinical Research Group Inc. — Sarnia, Ontario, Canada
- Centre Médical et Professionnel de l'Ouest de Portneuf — Saint-Marc-des-Carrieres, Quebec, Canada
- Alpha Recherche Clinique — Québec, Canada
- ALPHA Recherche Clinique — Québec, Canada
- Studium Egeszseghaz Kft — Kalocsa, Bács-Kiskun county, Hungary
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.